- Virtual Science AI has introduced a strategic research function for intelligent questions / answers that provides instant and personalized information on disease areas and treatments.
- The new improvement transforms the analysis of medical data by providing answers to complex strategic questions in seconds, accelerating decision -making of life sciences and the development of therapy.
- The pharmaceutical platform of Virtual Science AI fits perfectly into existing pharmaceutical processes and systems.
- By combining AI advanced technology with the validation of the man in a loop (HITL), the platform obtains an exceptional precision and speed, establishing new standards for information on health care without compromising quality.
London, January 29, 2025 (Globe Newswire) – Virtual science ai has established itself as a trusted partner for the life sciences teams. Using its proprietary information management and advice advice solutions, it transforms the complex analysis of scientific data into clear strategic information.
Thanks to continuous R&D investments, the company has developed SOC2 SOC2 Sophisticated SOC2 systems that are constantly evolving through automatic learning, incorporating new data and comments to improve their analytical capacities. This unique methodology, which also incorporates an expert human validation (human in the loop), allows Virtual Science IA to provide unrivaled precision while maintaining the necessary agility in the healthy environment at the rapid rate of today.
Relying on this robust basis, we are revealing today a new strategic research function for real -time intelligent questions / answers.
This new Advanced Question-answer research feature provides real-time summaries for data requests in seconds, helping life science teams to make faster and better informed decisions. As the platform serves users around the world, the system offers specific information to the country for complex strategic requests.
The question / answer function of the AI of virtual science changes the situation for life science societies which appreciate agility and need real -time exploitable perspectives to generate changes quickly, effectively and on a large scale .
Tom Hughes, The CEO, Virtual Science AI, explains the impact of the new platform feature:
“With the improvement of the virtual science medical intelligence platform, the new functionality of questions of questions / answers allows the life sciences of life to obtain strategic answers to secondary questions compared to traditional methods analysis of complex scientific data that could take months. “
Dr. Marco Avila, The chief doctor, Virtual Science IA, said:
“This AI advanced research function is that our customers have requested and is designed to improve strategic agility and improve the overall health of the population.”
For more information on virtual science ai’s insight solutions, visit: www.virtualScienceai.com.
On virtual science AI
Virtual Science IA is a global supplier of information management solutions and advice for AI for R&D affairs, medical affairs, public affairs, prices and access and commercial functions in science companies life and health care. Their owner medical intelligence platform transforms complex scientific data into usable information, which allows life sciences to generate a large-scale rapid and efficient change.
Based in London and with operations in Europe, North America, Asia-Pacific and Latin America, Virtual Science AI provides advanced software as (SaaS) service solutions for sectors of life and health. The company is associated with more than 20 main pharmaceutical companies and numerous biotechnology companies.
Contact with the media
Contact: Alison Doughty
Phone: +44 (0) 7703 611 620
E-mail: Alison.doughty@virtualScienceai.com
